Aptevo Therapeutics APVO Balance Sheet (2015-2026)

NASDAQ APVO
$2.76 +0.03 (+1.10%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
53.38M46.30M36.25M29.98M22.58M1.07M25.33M16.97M1.60M16.90M10.25M8.07M7.75M1.18M2.14M8.10M3.23M21.62M14.53M9.80M
Short-term Investments (Quarter)
1.26M
Cash & Current Investments (Quarter)
54.64M46.30M36.25M29.98M22.58M1.07M25.33M16.97M1.60M16.90M10.25M8.07M7.75M1.18M2.14M8.10M3.23M21.62M14.53M9.80M
Receivables - Net (Quarter)
3.10M3.66M3.11M
Receivables (Quarter)
3.10M3.66M3.11M
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)
Prepaid Assets (Quarter)
2.39M1.82M1.43M0.77M0.66M0.74M1.57M0.76M0.65M0.69M0.69M0.80M0.62M1.02M1.35M1.59M0.08M1.46M1.46M1.00M
Current Assets (Quarter)
58.87M52.57M41.67M31.40M24.62M27.45M28.48M22.68M21.13M19.07M12.07M9.58M10.01M10.66M3.61M11.08M22.65M23.08M15.98M10.80M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
2.52M2.38M2.14M1.89M1.67M1.46M1.28M1.13M1.01M0.90M0.79M0.70M0.61M0.54M0.48M0.43M0.38M0.30M0.27M0.24M
Goodwill (Quarter)
Intangibles (Quarter)
Goodwill & Intangibles (Quarter)
Other Non-Current Assets (Quarter)
0.75M0.07M0.07M0.55M0.43M
Non-Current Assets (Quarter)
5.13M4.03M3.51M7.40M7.08M6.76M6.48M6.23M6.00M5.78M5.55M5.34M5.13M4.93M4.74M4.54M4.35M4.11M3.92M3.72M
Assets (Quarter)
64.00M56.60M45.18M38.80M31.70M34.22M34.97M28.91M27.13M24.84M17.63M14.92M15.15M15.59M8.34M15.62M27.00M27.19M19.90M14.52M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.24M0.88M0.89M1.16M
Payables (Quarter)
1.24M0.88M0.89M1.16M
Accumulated Expenses (Quarter)
3.69M3.46M3.91M1.70M1.37M3.50M4.13M4.87M4.00M3.98M1.61M0.89M3.53M4.20M0.47M2.90M2.22M2.42M0.80M3.11M
Other Accumulated Expenses (Quarter)
2.59M2.09M1.59M0.03M1.17M1.10M1.04M0.75M1.31M1.14M0.97M0.79M1.43M0.36M1.13M0.95M1.49M0.25M0.41M0.45M
Short term Debt (Quarter)
11.17M11.67M2.00M2.00M2.00M2.00M
Current Leases (Quarter)
0.77M0.80M0.87M0.90M0.92M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)
32.38M34.76M23.86M7.00M7.79M8.71M5.80M6.91M6.84M7.22M6.30M5.42M5.88M6.21M5.39M4.89M5.61M6.05M4.76M5.19M
Non-Current Liabilities
Non-Current Debt (Quarter)
4.01M3.71M2.80M2.36M1.91M1.46M
Non-Current Deffered Revenue (Quarter)
Liabilities from Discontinued Operations (Quarter)
Non-Current Deferred Tax Liability (Quarter)
Operating Leases (Quarter)
1.61M1.34M1.06M6.39M6.24M6.10M5.90M5.75M5.60M5.40M5.20M5.00M4.80M4.60M4.40M4.21M3.99M3.76M3.53M3.30M
Other Non-Current Liabilities (Quarter)
18.71M15.58M23.34M0.01M0.01M0.01M
Total Non-Current Liabilities (Quarter)
38.00M39.80M27.73M16.24M12.62M11.51M10.44M10.71M10.84M9.81M
Total Liabilities (Quarter)
56.71M55.38M51.07M15.75M15.93M16.24M11.71M12.66M12.41M12.62M11.53M10.46M10.73M10.84M9.81M9.10M9.60M9.81M8.29M8.48M
Shareholder's Equity
Total Debt (Quarter)
15.18M15.37M4.80M4.36M3.91M3.46M
Common Equity (Quarter)
7.29M1.22M-5.88M23.05M15.76M17.97M23.26M16.25M14.72M12.22M6.10M4.46M4.42M4.75M-1.47M6.52M17.39M17.38M11.61M6.04M
Liabilities and Shareholders Equity (Quarter)
64.00M56.60M45.18M38.80M31.70M34.22M34.97M28.91M27.13M24.84M17.63M14.92M15.15M15.59M8.34M15.62M27.00M27.19M19.90M14.52M
Retained Earnings (Quarter)
-207.79M-214.06M-221.76M-193.75M-201.39M-206.04M-203.26M-211.21M-217.54M-223.45M-230.28M-236.16M-241.26M-247.58M-253.99M-260.19M-269.22M-275.12M-281.91M-288.26M
Treasury Shares (Quarter)
0.06M0.06M0.22M175.001.00